Burkitt Lymphoma Global Clinical Trials Review, H2, 2012


#155491

84pages

GlobalData

$ 2500

In Stock


Burkitt Lymphoma Global Clinical Trials Review, H2, 2012

Summary

GlobalData's clinical trial report, Burkitt Lymphoma Global Clinical Trials Review, H2, 2012" provides data on the Burkitt Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Burkitt Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Burkitt Lymphoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2

List of Tables 4
List of Figures 5
Introduction 6
Burkitt Lymphoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Unaccomplished Trials of Burkitt Lymphoma 20
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Top Companies Participating in Burkitt Lymphoma Therapeutics Clinical Trials 25
Prominent Drug Comparison 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Millennium Pharmaceuticals, Inc. 27
Clinical Trial Overview of Millennium Pharmaceuticals, Inc. 27
Pharmacyclics, Inc. 28
Clinical Trial Overview of Pharmacyclics, Inc. 28
Celldex Therapeutics, Inc. 29
Clinical Trial Overview of Celldex Therapeutics, Inc. 29
Novartis AG 30
Clinical Trial Overview of Novartis AG 30
Clinical Trial Overview of Top Universities / Institutes / Hospitals 31
Fred Hutchinson Cancer Research Center 31
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 31
Case Comprehensive Cancer Center 34
Clinical Trial Overview of Case Comprehensive Cancer Center 34
Wake Forest University 35
Clinical Trial Overview of Wake Forest University 35
The University of Texas M. D. Anderson Cancer Center 36
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 36
Mayo Clinic 37
Clinical Trial Overview of Mayo Clinic 37
Roswell Park Cancer Institute 38
Clinical Trial Overview of Roswell Park Cancer Institute 38
Barbara Ann Karmanos Cancer Institute 39
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 39
University of Nebraska 40
Clinical Trial Overview of University of Nebraska 40
Institut Gustave Roussy 41
Clinical Trial Overview of Institut Gustave Roussy 41
Masonic Cancer Center 42
Clinical Trial Overview of Masonic Cancer Center 42
Centro de Cancer del Hospital Auxilio Mutuo 43
Clinical Trial Overview of Centro de Cancer del Hospital Auxilio Mutuo 43
Erasmus MC 44
Clinical Trial Overview of Erasmus MC 44
Brown University 45
Clinical Trial Overview of Brown University 45
Northwestern University 46
Clinical Trial Overview of Northwestern University 46
Thomas Jefferson University 47
Clinical Trial Overview of Thomas Jefferson University 47
Sidney Kimmel Comprehensive Cancer Center 48
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 48
Dana-Farber Cancer Institute 49
Clinical Trial Overview of Dana-Farber Cancer Institute 49
University of Washington 50
Clinical Trial Overview of University of Washington 50
University of Pennsylvania 51
Clinical Trial Overview of University of Pennsylvania 51
Stanford University 52
Clinical Trial Overview of Stanford University 52
Five Key Clinical Profiles 53

Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 83
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 84

Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Burkitt Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10
Burkitt Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11
Burkitt Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
Burkitt Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13
Burkitt Lymphoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 14
Burkitt Lymphoma Therapeutics Clinical Trials, G7 Countries, 2012* 15
Burkitt Lymphoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 17
Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 18
Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 19
Burkitt Lymphoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 20
Burkitt Lymphoma Therapeutics Market, Global, Terminated Clinical Trials, 2012* 21
Burkitt Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 22
Burkitt Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24
Burkitt Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 25
Burkitt Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 26
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Millennium Pharmaceuticals, Inc., 2012* 27
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012* 28
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celldex Therapeutics, Inc., 2012* 29
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 30
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 31
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 34
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 35
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 36
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 37
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 38
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012* 39
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2012* 40
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Gustave Roussy, 2012* 41
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012* 42
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Centro de Cancer del Hospital Auxilio Mutuo, 2012* 43
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2012* 44
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Brown University, 2012* 45
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 46
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2012* 47
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012* 48
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 49
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2012* 50
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012* 51
Burkitt Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 52
Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Burkitt Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11
Burkitt Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
Burkitt Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 13
Burkitt Lymphoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 15
Burkitt Lymphoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 17
Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 18
Burkitt Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 19
Burkitt Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 22
Burkitt Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 23
Burkitt Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 25
Burkitt Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 26
GlobalData Methodology 82